Nir Knoll

Senior Associate

Chambers Global
“Pays great attention to detail and approaches legal matters with good strategy, taking into consideration legal and commercial needs.”
Legal 500
“Gifted deal-makers with a very impressive track record. Full devotion to the client’s needs.“
Legal 500
“A wide view not only from the legal perspective but also from the business one.”

ABOUT

Nir Knoll began his Israeli legal career at Gornitzky & Co. in 2014 as a legal intern and has continued as an associate.

Prior to joining Gornitzky, Nir served as an associate in the Mergers & Acquisitions and Corporate Finance Group of a leading New York law firm.

Nir is involved in representing the firm’s clients in a variety of corporate transactions, including domestic and cross-border M&A transactions (both inbound and outbound), equity offerings on foreign exchanges, private equity investments and general commercial matters.

Representative Transactions include:

  • Representing the shareholders of AHAVA Dead Sea Laboraties Ltd. in the sale of AHAVA’s share to the Fosun Group, a large Chinese conglomerate.
  • Representing Fortissimo in its acquisition of Tuttnauer Ltd., a leading manufacturer and supplier of autoclaves, washers and other sterilization applications and devices.
  • Representing Priority Software in its acquisition of Acclivity LLC, a U.S. based ERP software developer.
  • Representing International Flavors & Fragrances Inc. (IFF), a publicly traded company on the NYSE, in its acquisition by way of a reverse triangular merger of Frutarom Industries Ltd., a publicly traded company on the TASE.
  • Representing the underwriters in a USD 86 million secondary offering on the NASDAQ by Neuroderm, an Israeli company listed on the NASDAQ.
  • Representing the underwriters in a USD 57.5 million secondary offering on the NASDAQ by Intec Pharma, an Israeli company listed on both the NASDAQ and the Tel Aviv Stock Exchange.
  • Representing the underwriters in a USD 22.5 million secondary offering on the NASDAQ by Redhill BioPharma, an Israeli company listed on both the NASDAQ and the Tel Aviv Stock Exchange.
  • Representing the underwriters in a USD 11.2 million IPO on the NASDAQ by Entera Bio, an Israeli company.
  • Representing the underwriters in a USD 172.5 million secondary offering on the NASDAQ by Urogen, an Israeli company listed on both the NASDAQ.

M.A., Medieval Jewish History, Bernard Revel Graduate School (2009)
J.D., Harvard Law School (2001)
B.A., History, Yeshiva University (1998)

Israel Bar Association, 2014
New York State Bar, 2002

English and Hebrew

NEWS & PUBLICATIONS BY ADV. KNOLL

Hit enter to search or ESC to close